Astrana Health (ASTH) Receivables - Other (2011 - 2026)

Astrana Health (ASTH) has 16 years of Receivables - Other data on file, last reported at $28.0 million in Q1 2026.

• Quarterly Receivables - Other rose 87.79% year-over-year to $28.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $28.0 million (up 87.79% YoY) and the FY2025 annual result came in at $26.4 million, down 10.55% from the prior year.
• Receivables - Other improved to $28.0 million in Q1 2026 per ASTH's latest filing, from $26.4 million in the prior quarter.
• The five-year high for Receivables - Other was $76.4 million in Q1 2022, with the low at $1.1 million in Q3 2024.
• Average Receivables - Other over 5 years is $20.2 million, with a median of $11.6 million recorded in 2022.
• The widest YoY moves for Receivables - Other: up 2109.44% in 2024, down 97.62% in 2024.
• Astrana Health's Receivables - Other stood at $11.6 million in 2022, then plunged by 88.49% to $1.3 million in 2023, then soared by 2109.44% to $29.5 million in 2024, then dropped by 10.55% to $26.4 million in 2025, then increased by 6.19% to $28.0 million in 2026.
• Business Quant data shows ASTH's Receivables - Other at $28.0 million in Q1 2026, $26.4 million in Q4 2025, and $9.9 million in Q3 2025.